High-Dose Methotrexate of No CNS Benefit in High-Risk DLBCL ...Middle East

Patients with high-risk diffuse large B-cell lymphoma (DLBCL) have a greater than 10% risk of central nervous system (CNS) relapse. Medscape Medical News

Hence then, the article about high dose methotrexate of no cns benefit in high risk dlbcl was published today ( Wednesday 19/05/2021 - 10:45 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( High-Dose Methotrexate of No CNS Benefit in High-Risk DLBCL )

Also on site :

• 2000s Heavy Metal Rocker Makes $1.5 Million Move Before 2026 Tour
• Iran strikes fully loaded Kuwaiti oil tanker at Dubai port; spill risk flagged
• “Bolivia no duerme”: entre la confianza y el nerviosismo, un país entero espera el repechaje al Mundial 2026